Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal iPS cell-derived exosomes for age-related mild cognitive impairment
jRCT1033250410Completed
- Sponsor
- XPRIZE Foundation
- Start
- Oct 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial in Mild Cognitive Impairment (MCI) (3 arms), sponsored by XPRIZE Foundation. Primary endpoints: Change in MMSE score at 6 weeks and Change in MoCA-J score at 6 weeks. Started Oct 2025; status: completed.
02
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on jRCT1033250410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1033250410.